Ramón Salazar
A5035175323- Colorectal Cancer Treatments and Studies
- Genetic factors in colorectal cancer
- Cancer Genomics and Diagnostics
- Neuroendocrine Tumor Research Advances
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Surgical Treatments
- Cancer Treatment and Pharmacology
- Neuroblastoma Research and Treatments
- Colorectal and Anal Carcinomas
- Colorectal Cancer Screening and Detection
- Cancer Research and Treatments
- COVID-19 and healthcare impacts
- Advanced Breast Cancer Therapies
- Pancreatic and Hepatic Oncology Research
- TGF-β signaling in diseases
- Cancer Cells and Metastasis
- COVID-19 Clinical Research Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Immunotherapy and Biomarkers
- Innovative Microfluidic and Catalytic Techniques Innovation
- Epigenetics and DNA Methylation
- Radiomics and Machine Learning in Medical Imaging
- CAR-T cell therapy research
Institut d'Investigació Biomédica de Bellvitge
2016-2025
Institut Català d'Oncologia
2016-2025
Centro de Investigación Biomédica en Red de Cáncer
2017-2025
Universitat de Barcelona
2015-2025
Bellvitge University Hospital
2011-2023
Institut Català d'Ornitologia
2008-2023
Departament de Salut
2023
Duran i Reynals Hospital
2012-2022
Instituto de Salud Carlos III
2017-2022
European Society for Medical Oncology
2022
The goal of this paper is to update a more extensive review and guidelines published in 2012 [1] . Gen-erally, any pertinent pertaining the diagnosis staging individual prima ...
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms Foregut, Midgut, Hindgut, Unknown Primary
Guidelines| December 29 2011 ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes Subject Area: Endocrinology , Neurology and Neuroscience Robert T. Jensen; Jensen Diseases Branch, NIH, Bethesda, Md., USA; Search other works by this author on: This Site PubMed Google Scholar Guillaume Cadiot; Cadiot Service d'Hépato-Gastroentérologie, CHU de Reims, Hôpital Debré, France; Maria L. Brandi; Brandi...
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms System : Well-Differentiated Pancreatic Non-Functioning Tumors
Purpose This study aims to develop a robust gene expression classifier that can predict disease relapse in patients with early-stage colorectal cancer (CRC). Patients and Methods Fresh frozen tumor tissue from 188 stage I IV CRC undergoing surgery was analyzed using Agilent 44K oligonucleotide arrays. Median follow-up time 65.1 months, the majority of (83.6%) did not receive adjuvant chemotherapy. A nearest mean developed cross-validation procedure score all genes for their association...
however, is covered in this chapter, since early recognition and treatment important for complication of carcinoid syndrome.Since highly proliferative carcinomas with a neuroendocrine phenotype but poor histological differentiation grade are extremely rare the jejuno-ileum, management such cases remains individual can currently not be considered standardised according to organ-oriented guidelines.For cases, reader referred previous guidelines [4] .This therefore, deals non-metastatic NEN...
SummaryInhibitors of the ALK and EGF receptor tyrosine kinases provoke dramatic but short-lived responses in lung cancers harboring EML4-ALK translocations or activating mutations EGFR, respectively. We used a large-scale RNAi screen to identify MED12, component transcriptional MEDIATOR complex that is mutated cancers, as determinant response EGFR inhibitors. MED12 part cytoplasmic where it negatively regulates TGF-βR2 through physical interaction. suppression therefore results activation...
In most colorectal cancer (CRC) patients, outcome cannot be predicted because tumors with similar clinicopathological features can have differences in disease progression and treatment response. Therefore, a better understanding of the CRC biology is required to identify those patients who will benefit from chemotherapy find more tailored therapy plan for other patients. Based on unsupervised classification whole genome data 188 stages I–IV molecular was developed that consist at least three...
Guidelines| December 29 2011 ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms Subject Area: Endocrinology , Neurology and Neuroscience Gianfranco Delle Fave; Fave aDepartment Digestive Liver Disease, Ospedale Sant'Andrea, Rome, Italy; Search other works by this author on: This Site PubMed Google Scholar Dik J. Kwekkeboom; Kwekkeboom bDepartment Oncology, Royal Free University UFR Bichat-Beaujon-Louis Mourier, Colombes, France; Erik Van Cutsem; Cutsem...
Guidelines| December 29 2011 ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neoplasms Subject Area: Endocrinology , Neurology and Neuroscience Martyn Caplin; Caplin aDepartment Gastroenterology, Royal Free Hospital, London, UK; Search other works by this author on: This Site PubMed Google Scholar Anders Sundin; Sundin bDepartment Radiology, Marsden Sutton, Ola Nillson; Nillson cDepartment Pathology, Gothenburg University,...
Abstract The SARS-CoV-2 pandemic significantly affected oncology practice across the globe. There is uncertainty as to contribution of patients' demographics and oncologic features severity mortality from COVID-19 little guidance role anticancer anti–COVID-19 therapy in this population. In a multicenter study 890 patients with cancer confirmed COVID-19, we demonstrated worsening gradient breast hematologic malignancies showed that male gender, older age, number comorbidities identify subset...
Circulating tumor DNA (ctDNA) is a potential source for genome analysis. We explored the concordance between mutational status of RAS in tissue and ctDNA metastatic colorectal cancer (mCRC) patients to establish eligibility anti-epidermal growth factor receptor (EGFR) therapy.A prospective-retrospective cohort study was carried out. Tumor from 146 mCRC tested with standard care (SoC) PCR techniques, Digital (BEAMing) used both plasma tissue.ctDNA BEAMing testing showed 89.7% agreement SoC...